We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -3.39% | 2.85 | 2.80 | 2.90 | 2.95 | 2.85 | 2.90 | 2,684,036 | 08:23:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 13.09M | -33.29M | -0.0429 | -0.66 | 22.88M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/10/2024 10:10 | I think £1 million was not paid until 30th sept and Canada has not started yet. So £0.8 milion inclueds Europe and 250k from Canada approval. | krp10 | |
29/10/2024 10:07 | a couple of things do not make sense net sell revenue from US is 7.2m, they also have milestone of 1m, so don't understand why the total is 8m, or this has not been paid so not take into consideration? Also, what is the revenue from other countries? I feel the number is not reflecting the complete picture, the total revenue should be higher. | qipincha | |
29/10/2024 10:06 | I repeat listen to PATT at your peril. | parob | |
29/10/2024 09:53 | Actually it just depends on revenues.Go look at other iron drugs and tell me why this one will be different.Although, I do recognise their battle is getting into a generics dominated market, which isn't easy.But it's doable with persistence and skill. Agree they've lacked some skill.I'm disappointed with this quarter but it doesn't mean the games up especially while AOP are all in | skcots48 | |
29/10/2024 09:51 | I understand issues with previous head. But it is not the case now. If the business model has an issue, AOP will simply not invest in the company | qipincha | |
29/10/2024 09:50 | That is a ridiculous reaction to continued growth, sorting out funding, reducing costs snd repeating cash burn ends close of 2025 with Rx continuing to rise. | purchaseatthetop | |
29/10/2024 09:28 | This business model was destroyed years ago, I don’t see it coming back, tens of millions will be needed, more and more dilution. Blame the previous reckless management, mugs just buying dead cat bounces. | ny boy | |
29/10/2024 09:19 | No panic. This is manipulation by those who want to hoover up cheap shares | wheeze | |
29/10/2024 09:00 | Not sure why panic As far as I can see all heading to the right direction Extra funding is to ensure growing plan And funding is supported by AOP not us To make profit at the end of 2025 is a target not too far now | qipincha | |
29/10/2024 08:54 | Bones. You should have posted that on on POLX | purchaseatthetop | |
29/10/2024 08:45 | Generally no. But where PATT is concerned yes. Witnessed it over the last few years.His arrogance is off the scale. | parob | |
29/10/2024 08:41 | Oh dear sales slowing and heading south In a hurry after the update disappointed . Hard to see a future decent business here . | bones698 | |
29/10/2024 08:30 | Firstly, apologies Skots, I didn't and frankly still don't understand wholesalers stocking up in July. They managed to hit the neutral point, near enough hitting exactly what I thought in terms of count, but £500k shy on revenue. 4p will be a bit of an anchor both ways - buying under is something of a free hit. | hpcg | |
29/10/2024 08:25 | So you believe in jinxes parrot? | zeus19 | |
29/10/2024 08:25 | Boiler room boys in panic mode Heading below 1p Get out whilst you can Leaking sinking boat | hamidahamida | |
29/10/2024 08:25 | Yep another share that PATT has jinxed.He does what his avatar says, buys at the top and then the shares tend to dive. If he buys in, best to get out imo.I have been saying this but have been called out for it. | parob | |
29/10/2024 08:18 | Agree base. Director buying would make a statement. | purchaseatthetop | |
29/10/2024 08:17 | Funding at 4p is certainly better than & takeover by AOP at 2.5p & we are still in the game.Disappointing that there has been clearly large volume selling ahead of the 4p raise ,yet again - which is a disgrace-& illegal- not the Regulators will take action. $11.5mill revenue in Q4 is positive as it infers FY25 revenues of over $50mill-assuming we achieve modest quarterly growth in FY25 + revenues from Canada should start along with South Korea ( hopefully ) Could have been much worse & lets see what Batman & Robin have to say on Thursday & whether they will back up their expected confidence with actual share buying. | base7 | |
29/10/2024 08:16 | Another Richard Bobath clanger .. best contra indicator in the market when that conman buys in | dplewis1 | |
29/10/2024 08:13 | A long and troubling road ahead with lots of cash raises. let’s see what mr Market makes of all this fluffy rns | ny boy | |
29/10/2024 08:04 | All looks perfectly reasonable and meeting broker forecasts which also suggest a muchhigher fair value. Brainless trashing comments have a clear motivation. | photon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions